Biotechnology stocks
1,362 listed biotechnology companies, ordered by market capitalisation, inside the Health Care sector. Every one has a free page with its price history, key figures and Tweenvest factor scores.
| Company | Market cap | Price | Day |
|---|---|---|---|
| ALX Oncology Holdings Inc.NasdaqGS: ALXO | $171.46M | $1.24 | +8.77% |
| IntoCell, Inc.KOSDAQ: A287840 | $167.77M | ₩14,890.00 | -14.03% |
| Pacific Edge LimitedNZSE: PEB | $165.18M | NZ$0.24 | +2.17% |
| Whitehawk Therapeutics, Inc.NasdaqCM: WHWK | $164.76M | $2.89 | -17.90% |
| GC Genome CorporationKOSDAQ: A340450 | $163.74M | ₩9,230.00 | -6.48% |
| ImmuneOnco Biopharmaceuticals (Shanghai) Inc.SEHK: 1541 | $163.11M | HK$2.98 | -4.64% |
| Coherus Oncology, Inc.NasdaqGM: CHRS | $162.23M | $1.05 | +2.94% |
| HEM Pharma Inc.KOSDAQ: A376270 | $162.22M | ₩30,000.00 | -5.06% |
| Dx & Vx Co., Ltd.KOSDAQ: A180400 | $161.68M | ₩2,190.00 | -6.01% |
| Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.SEHK: 2566 | $159.97M | HK$5.23 | -7.19% |
| Biomm S.A.BOVESPA: BIOM3 | $158.78M | R$5.90 | -19.62% |
| TYK Medicines, IncSEHK: 2410 | $158.08M | HK$3.23 | -8.77% |
| Entrada Therapeutics, Inc.NasdaqGM: TRDA | $157.57M | $4.37 | -22.93% |
| curacle co.,ltd.KOSDAQ: A365270 | $155.89M | ₩9,380.00 | -3.99% |
| BioInvent International AB (publ)OM: BINV | $155.48M | Skr23.40 | +0.86% |
| Compass Therapeutics, Inc.NasdaqCM: CMPX | $154.88M | $0.86 | -13.39% |
| NovaBridge BiosciencesNasdaqGM: NBP | $154.28M | $1.33 | -2.92% |
| Innovacell Inc.TSE: 504A | $154.15M | ¥539.00 | -0.92% |
| Bioneer CorporationKOSDAQ: A064550 | $153.91M | ₩7,950.00 | -6.03% |
| Medigen Biotechnology Corp.TPEX: 3176 | $152.42M | NT$35.50 | -5.46% |
| GC Cell CorporationKOSDAQ: A144510 | $151.26M | ₩13,420.00 | -8.08% |
| Upstream Bio, Inc.NasdaqGS: UPB | $151.17M | $2.76 | -41.28% |
| Scancell Holdings plcAIM: SCLP | $150.40M | £0.09 | +0.54% |
| Mycenax Biotech Inc.TPEX: 4726 | $148.05M | NT$23.20 | -2.52% |
| BNC KOREA, Inc.KOSDAQ: A256840 | $147.75M | ₩2,880.00 | -5.88% |
| AptaBio Therapeutics Inc.KOSDAQ: A293780 | $146.87M | ₩6,970.00 | -12.22% |
| Essex Bio-Technology LimitedSEHK: 1061 | $146.70M | HK$2.03 | -0.25% |
| Acumen Pharmaceuticals, Inc.NasdaqGS: ABOS | $145.72M | $2.02 | +13.84% |
| Molecular Partners AGSWX: MOLN | $144.13M | CHF3.10 | -3.43% |
| CANbridge Pharmaceuticals Inc.SEHK: 1228 | $143.50M | HK$1.89 | -1.57% |
| Helixmith Co., LtdKOSDAQ: A084990 | $140.92M | ₩4,080.00 | -9.93% |
| Saniona AB (publ)OM: SANION | $140.91M | Skr10.11 | +5.64% |
| Cloudbreak Pharma Inc.SEHK: 2592 | $140.32M | HK$— | — |
| Bioventix PLCAIM: BVXP | $139.67M | £20.00 | +2.56% |
| Satellos Bioscience Inc.TSX: MSCL | $138.74M | CA$9.25 | -13.63% |
| Adagene Inc.NasdaqGM: ADAG | $138.32M | $2.06 | -25.36% |
| BRIM Biotechnology, Inc.TWSE: 6885 | $137.80M | NT$33.60 | +13.51% |
| Anbio BiotechnologyNasdaqGM: NNNN | $137.38M | $3.13 | -32.83% |
| Cue Biopharma, Inc.NasdaqCM: CUE | $137.22M | $18.89 | -0.32% |
| Outlook Therapeutics, Inc.NasdaqCM: OTLK | $137.18M | $0.56 | +0.39% |
| Protara Therapeutics, Inc.NasdaqGM: TARA | $137.10M | $2.32 | -15.79% |
| Innate Pharma S.A.ENXTPA: IPH | $136.89M | €1.30 | -3.26% |
| Jyong Biotech Ltd.NasdaqGM: MENS | $136.59M | $1.84 | -12.38% |
| UnicoCell Biomed Co., Ltd.TWSE: 6794 | $136.51M | NT$69.60 | -2.79% |
| Burning Rock Biotech LimitedNasdaqGM: BNR | $136.05M | $12.90 | -16.72% |
| Tiziana Life Sciences LtdNasdaqCM: TLSA | $135.77M | $1.05 | -11.76% |
| JW (Cayman) Therapeutics Co. LtdSEHK: 2126 | $135.51M | HK$2.62 | -7.26% |
| Kangstem Biotech Co., Ltd.KOSDAQ: A217730 | $135.31M | ₩1,918.00 | -7.12% |
| Canton Strategic Holdings, Inc.NasdaqCM: CNTN | $135.06M | $1.70 | -19.67% |
| Organogenesis Holdings Inc.NasdaqCM: ORGO | $132.53M | $1.03 | +3.90% |
| Atrium Therapeutics, Inc.NasdaqGS: RNA | $131.20M | $7.67 | -8.69% |
| NeoImmuneTech, Inc.KOSDAQ: A950220 | $129.77M | ₩1,750.00 | -7.51% |
| Nkarta, Inc.NasdaqGS: NKTX | $128.92M | $1.80 | -20.00% |
| NKGen Biotech Korea Co., Ltd.KOSDAQ: A182400 | $128.86M | ₩— | — |
| NIBEC Co., Ltd.KOSDAQ: A138610 | $128.76M | ₩15,100.00 | -3.51% |
| Pharma Foods International Co., Ltd.TSE: 2929 | $127.48M | ¥693.00 | +0.87% |
| Orthocell LimitedASX: OCC | $126.99M | AU$0.67 | -2.90% |
| Anavex Life Sciences Corp.NasdaqGS: AVXL | $126.07M | $1.36 | +1.10% |
| 3billion, Inc.KOSDAQ: A394800 | $125.79M | ₩5,270.00 | -10.68% |
| Armata Pharmaceuticals, Inc.NYSEAM: ARMP | $125.30M | $3.37 | -7.16% |
| Sunho Biologics, Inc.SEHK: 2898 | $123.78M | HK$— | — |
| Aroa Biosurgery LimitedASX: ARX | $122.75M | AU$0.51 | -1.92% |
| Actinogen Medical LimitedASX: ACW | $120.48M | AU$0.05 | -18.18% |
| Black Diamond Therapeutics, Inc.NasdaqGS: BDTX | $118.93M | $2.07 | +14.36% |
| ISU Abxis Co., Ltd.KOSDAQ: A086890 | $117.75M | ₩3,850.00 | -3.27% |
| StemCyte International, Ltd.TWSE: 4178 | $117.10M | NT$17.60 | -10.20% |
| Bio Solution Co.,Ltd.KOSDAQ: A086820 | $116.32M | ₩6,010.00 | -8.80% |
| Heidelberg Pharma AGXTRA: HPHA | $115.79M | €2.20 | -1.35% |
| Cereno Scientific AB (publ)OM: CRNO B | $115.50M | Skr3.53 | -7.54% |
| Humacyte, Inc.NasdaqGS: HUMA | $114.76M | $0.41 | +0.46% |
| Voyager Therapeutics, Inc.NasdaqGS: VYGR | $114.61M | $1.86 | -7.92% |
| Spruce Biosciences, Inc.NasdaqCM: SPRB | $113.95M | $39.65 | -9.99% |
| Hamlet BioPharma AB (publ)XSAT: HAMLET B | $113.40M | Skr— | — |
| Minerva Neurosciences, Inc.NasdaqCM: NERV | $112.21M | $2.35 | -26.10% |
| TuHURA Biosciences, Inc.NasdaqCM: HURA | $112.16M | $1.76 | -10.20% |
| enGene Therapeutics Inc.NasdaqCM: ENGN | $111.92M | $1.67 | -3.47% |
| Pharmosa Biopharm Inc.TPEX: 6875 | $111.29M | NT$27.95 | +3.52% |
| Tevogen Inc.NasdaqGM: TVGN | $111.26M | $7.07 | +4.28% |
| Vaxart, Inc.OTCPK: VXRT | $110.10M | $0.45 | +4.21% |
| Foghorn Therapeutics Inc.NasdaqGM: FHTX | $109.86M | $1.85 | -7.50% |
| Unicycive Therapeutics, Inc.NasdaqCM: UNCY | $109.75M | $3.94 | +17.26% |
| 4basebio PLCAIM: 4BB | $108.83M | £5.25 | -6.67% |
| Genelux CorporationNasdaqCM: GNLX | $108.45M | $2.42 | -5.47% |
| ArcticZymes Technologies ASAOB: AZT | $108.36M | Nkr19.85 | -1.73% |
| Anterogen.Co.,Ltd.KOSDAQ: A065660 | $108.08M | ₩14,400.00 | -11.06% |
| Nykode Therapeutics ASOB: NYKD | $108.07M | Nkr3.13 | -9.16% |
| Paradigm Biopharmaceuticals LimitedASX: PAR | $104.36M | AU$— | — |
| Maxigen Biotech Inc.TWSE: 1783 | $103.67M | NT$37.50 | -1.57% |
| Great Novel Therapeutics Biotech & MedicalsTPEX: 7427 | $102.58M | NT$62.90 | -4.84% |
| Shine-On BioMedical Co.,Ltd.TPEX: 6926 | $101.61M | NT$66.20 | -0.45% |
| BioGend Therapeutics Co., Ltd.TPEX: 6733 | $101.01M | NT$24.40 | -2.01% |
| Cibus, Inc.NasdaqCM: CBUS | $100.89M | $1.32 | -14.84% |
| Coya Therapeutics, Inc.NasdaqCM: COYA | $99.70M | $4.25 | -14.14% |
| Kazia Therapeutics LimitedNasdaqCM: KZIA | $99.35M | $7.25 | -18.81% |
| Faron Pharmaceuticals OyAIM: FARN | $99.19M | £0.36 | -1.37% |
| Immunic, Inc.NasdaqCM: IMUX | $98.51M | $7.22 | -3.48% |
| Insight Molecular Diagnostics Inc.NasdaqCM: IMDX | $98.50M | $3.01 | -10.68% |
| Novogenia AGMUN: 7V0 | $98.11M | €— | — |
| ImmuCell CorporationNasdaqCM: ICCC | $97.63M | $10.75 | +9.69% |
| Pet Pharm Biotech Co., Ltd.TPEX: 7762 | $96.68M | NT$54.00 | -2.88% |